Greater Boston Area
Product Pipeline:
OTC (Over-the-Counter) Consumer Product:
SUGARDOWN® is a chewable dietary supplement designed to moderate post-meal blood glucose. It is to be taken before meals and works non-systemically in the gastrointestinal tract to block the action of carbohydrate-hydrolyzing enzymes which break down complex carbohydrates into glucose. SUGARDOWN® is commercially available at www.sugardown.com
Pharmaceutical Products:
www.bostonti.com
PAZAMET™ is a new, chewable tablet formulation of the diabetes drug metformin. The Company won FDA approval to file an Abbreviated New Drug Application (ANDA).
PAZ320 is a non-systemic, chewable drug candidate for reduction of post-meal blood glucose in diabetics and pre-diabetics. The compound completed a phase II clinical trial at Dartmouth-Hitchcock Medical Center in New Hampshire.
Oxygen Therapy Inc.
Chairman of the Board
Oxygen Therapy Inc.
April 2016 – 2016 (less than a year)
Oxygen Therapy Inc (OTI) is a biopharmaceutical company focused on the development and commercialization of first-in-class treatments for hypoxic conditions and necrosis prevention. Our initial targeted medical conditions are wound healing, trauma and stroke
Galectin Therapeutics formally Pro-pharmaceuticals
CEO/Chairman founder
Galectin Therapeutics formally Pro-pharmaceuticals
June 2000 – December 2008 (8 years 7 months)
AMEX PRW
OTCBB PRWP.OB
International gene group
Chaiman/CEO Founder
International gene group
June 1994 – May 2000 (6 years)
nasdaq. SAFS, IGGI, GLGS
Projects
Galectin-3 receptor
May 1988 – February 2009
Galectin-3 is important in inflamation.
Team members:
G Medicine Inc. (NasdaqBGMD), Galectin Therapeutics (NasdaqGALT), La Jolla pharmaceuticals (OTC LJPC)
Carbohydrate Hydrolyzing Enzymes Inhibitors (CHEI)
Starting February 2009
Alosteric Inhibition of Carbohydrate Hydrolyzing Enzymes
Team members:
David Platt, No one
Carbohydrate Linker Technology
Team members:
David Platt[/b]
Languages
Hebrew
Skills
Polymer Chemistry
Carbohydrate Chemistry
Biotechnology
Lifesciences
Pharmaceutical Industry
Drug Discovery
R&D
Technology Transfer
Clinical Development
Commercialization
Biopharmaceuticals
Drug Development
Oncology
Drug Delivery
Regulatory Affairs
Pharmaceutics
FDA
Diabetes
Clinical Trials
Biochemistry
Hardware Diagnostics
Sop
Molecular Biology
CTMS
CRO
Patents
Medicine
Cancer
Drug Design
Validation
Chemistry
GLP
GMP
Immunology
Corporate Development
Start-ups
Vaccines
Competitive Intelligence
Pharmacology
Venture Capital
Formulation
Infectious Diseases
Regulatory Submissions
Licensing
Angel Investing
Cell
Clinical Research
Laboratory
Life Sciences
Medical Writing
Education
Wizmann Institute Rehovot
Wizmann Institute Rehovot
Doctor of Philosophy - PhD, Carbohydrate Chemistry
1984 – 1988
Activities and Societies: American Chemical Society American Diabetes Association American Heart Association
The Hebrew University
The Hebrew University
PhD, Chemistry
1983 – 1986
Founder of 2 publically traded biotechnology companies Nasdaq/AMEX
Editor of two text books:
- Carbohydrate Drug Design
- Galectins
Activities and Societies: American Chemical Society (ACS)
alliance ramat aviv
alliance ramat aviv
High school diploma, Theoretical and Mathematical Physics
1968 – 1971
Groups
TWO KEY CANCER CONFERENCES
TWO KEY CANCER CONFERENCES
Biotech, Medical & Pharmaceutical Investment
Biotech, Medical & Pharmaceutical Investment
Biotechnology and Pharmaceutical Network (Gi)
Biotechnology and Pharmaceutical Network (Gi)
Pharma Connections Worldwide
Pharma Connections Worldwide
Global Diabetes Alliance (Gi)
Global Diabetes Alliance (Gi)
Life Sciences Israel TM 2015 Conference - Partnering Event of the Year
Life Sciences Israel TM 2015 Conference - Partnering Event of the Year
Boston Biotech
Boston Biotech
Health 2.0
Health 2.0
Stroke Survivors Network
Stroke Survivors Network
DealFlow Source Network | Private Equity, Venture Capital, M&A Deal Flow
DealFlow Source Network | Private Equity, Venture Capital, M&A Deal Flow
Cannabis Medical and Recreational Insider
Cannabis Medical and Recreational Insider[/b]
Medical Group Management Association (MGMA)
Medical Group Management Association (MGMA)
Innovation (Gi)
Innovation (Gi)
People Also Viewed
José Alexandre de Freitas da Cunha F.
Chairman at Idealmed SGPS
Neil Parikh
CEO/President & Founder of Axar Pharmaceuticals, Inc.
Robert Uptegraff
Chairman of the Board/ CEO at Faccec Inc.
Lee Stern
Gary Jacob
Chairman & CEO at Synergy Pharmaceuticals, Inc.
Jeffrey Green
Partner; Bain Capital Life Sciences
William Foley
Chairman and CEO of Libbey Inc.
Camille Samuels
James Slaughter
Chairman of the Board and CEO Emeritus
Public profile badge
Include this LinkedIn profile on other websites
There's more to
